Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 9 studies | 47% ± 17% | |
endothelial cell of lymphatic vessel | 8 studies | 22% ± 7% | |
astrocyte | 7 studies | 37% ± 15% | |
cardiac muscle cell | 4 studies | 30% ± 13% | |
hepatocyte | 4 studies | 55% ± 24% | |
epithelial cell | 3 studies | 19% ± 2% |
Insufficient scRNA-seq data for expression of PLIN5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 12923.95 | 226 / 226 | 97% | 24.44 | 393 / 406 |
prostate | 88% | 2278.53 | 215 / 245 | 79% | 9.30 | 396 / 502 |
breast | 87% | 3533.00 | 398 / 459 | 57% | 7.26 | 642 / 1118 |
pancreas | 100% | 8021.07 | 328 / 328 | 42% | 1.97 | 75 / 178 |
thymus | 77% | 1219.56 | 500 / 653 | 60% | 2.80 | 362 / 605 |
kidney | 99% | 2995.42 | 88 / 89 | 37% | 2.31 | 330 / 901 |
ovary | 97% | 10503.55 | 175 / 180 | 21% | 0.78 | 89 / 430 |
bladder | 62% | 1236.19 | 13 / 21 | 44% | 4.85 | 223 / 504 |
stomach | 96% | 5201.73 | 344 / 359 | 7% | 0.17 | 19 / 286 |
muscle | 100% | 10073.84 | 801 / 803 | 0% | 0 | 0 / 0 |
adipose | 95% | 4634.07 | 1141 / 1204 | 0% | 0 | 0 / 0 |
heart | 92% | 3414.60 | 793 / 861 | 0% | 0 | 0 / 0 |
lung | 64% | 1147.41 | 372 / 578 | 24% | 1.16 | 280 / 1155 |
peripheral blood | 69% | 3384.99 | 639 / 929 | 0% | 0 | 0 / 0 |
brain | 42% | 504.66 | 1110 / 2642 | 24% | 1.03 | 166 / 705 |
spleen | 61% | 918.16 | 146 / 241 | 0% | 0 | 0 / 0 |
esophagus | 51% | 886.14 | 734 / 1445 | 9% | 0.42 | 16 / 183 |
uterus | 27% | 409.54 | 46 / 170 | 24% | 1.43 | 111 / 459 |
adrenal gland | 40% | 526.92 | 102 / 258 | 7% | 0.36 | 15 / 230 |
intestine | 28% | 387.91 | 268 / 966 | 8% | 0.28 | 43 / 527 |
skin | 18% | 356.86 | 318 / 1809 | 1% | 0.11 | 7 / 472 |
eye | 0% | 0 | 0 / 0 | 15% | 0.50 | 12 / 80 |
blood vessel | 9% | 227.46 | 122 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.28 | 3 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.16 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060192 | Biological process | negative regulation of lipase activity |
GO_0031999 | Biological process | negative regulation of fatty acid beta-oxidation |
GO_0010890 | Biological process | positive regulation of sequestering of triglyceride |
GO_0010897 | Biological process | negative regulation of triglyceride catabolic process |
GO_0032000 | Biological process | positive regulation of fatty acid beta-oxidation |
GO_0060193 | Biological process | positive regulation of lipase activity |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_0010867 | Biological process | positive regulation of triglyceride biosynthetic process |
GO_0035359 | Biological process | negative regulation of peroxisome proliferator activated receptor signaling pathway |
GO_0019915 | Biological process | lipid storage |
GO_0034389 | Biological process | lipid droplet organization |
GO_0051646 | Biological process | mitochondrion localization |
GO_0010884 | Biological process | positive regulation of lipid storage |
GO_0005811 | Cellular component | lipid droplet |
GO_0005739 | Cellular component | mitochondrion |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0035473 | Molecular function | lipase binding |
Gene name | PLIN5 |
Protein name | Perilipin-5 (Lipid storage droplet protein 5) Perilipin 5 |
Synonyms | LSDP5 OXPAT PAT-1 |
Description | FUNCTION: Lipid droplet-associated protein that maintains the balance between lipogenesis and lipolysis and also regulates fatty acid oxidation in oxidative tissues. Recruits mitochondria to the surface of lipid droplets and is involved in lipid droplet homeostasis by regulating both the storage of fatty acids in the form of triglycerides and the release of fatty acids for mitochondrial fatty acid oxidation. In lipid droplet triacylglycerol hydrolysis, plays a role as a scaffolding protein for three major key lipolytic players: ABHD5, PNPLA2 and LIPE. Reduces the triacylglycerol hydrolase activity of PNPLA2 by recruiting and sequestering PNPLA2 to lipid droplets. Phosphorylation by PKA enables lipolysis probably by promoting release of ABHD5 from the perilipin scaffold and by facilitating interaction of ABHD5 with PNPLA2. Also increases lipolysis through interaction with LIPE and upon PKA-mediated phosphorylation of LIPE (By similarity). . |
Accessions | Q00G26 ENST00000586133.1 ENST00000381848.7 K7EIX1 ENST00000592610.1 |